Dafna Capital Management LLC Cytom X Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$6.55 - $8.83 $39,955 - $53,863	-6,100 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$7.4 - $14.64 $694,860 - $1.37 Million	-93,900 Reduced 93.9%	6,100 $51,000
Q3 2019 Nov 14, 2019	BUY	$7.38 - $12.25 $738,000 - $1.23 Million	100,000 New	100,000 $738,000
Q4 2017 Feb 14, 2018	SELL	$19.0 - $23.09 $112,100 - $136,231	-5,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $79,827 - $107,203	5,900	5,900 $107,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.